Partial splenic embolization reverses insulin resistance in patients with liver cirrhosis

Internal Medicine

Volumn 48, Issue 10, 2009, Pages 747-751

  Shimizu, Hirohito ^a   Takatsuka, Kentaro ^a   Yoshida, Atsushi ^a   Yoshimatsu, Eiki ^a   Matsui, Keiji ^a   Iwabuchi, Shogo ^a  

^a Ofuna Chuo Hospital   (Japan)

Author keywords

Hepatic glucose uptake; Insulin resistance; Liver cirrhosis; Partial splenic embolization

Indexed keywords

HEPATITIS C ANTIGEN; INSULIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BEDTIME DOSAGE; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; HEPATITIS C; HUMAN; INSULIN RESISTANCE; INTESTINE BLOOD FLOW; LIVER BLOOD FLOW; LIVER CIRRHOSIS; MALE; MORNING DOSAGE; OUTCOME ASSESSMENT; SPLEEN BLOOD FLOW; SPLEEN EMBOLIZATION; THROMBOCYTE COUNT; TREATMENT RESPONSE; VEIN BLOOD FLOW; VIRUS LOAD;

AGED; BLOOD FLOW VELOCITY; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; PORTAL VEIN; SPLENIC VEIN;

EID: 67649958487     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1649     Document Type: Article

References (14)

1. Lee CM, Leung TK, Wang HJ, et al. Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia. World J Gastroenterol 13: 619-622, 2007.
2. Foruny JR, Blazquez J, Moreno A, et al. Safe use of pegylated interferon/ ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization. Eur J Gastroenterol Hepatol 17: 1157-1164, 2005.
3. Ohmoto K, Yamamoto S. Prevention of variceal recurrence, bleeding, and death in cirrhosis patients with hypersplenism, especially those with severe thrombocytopenia. Hepatogastroenterology 50: 1766-1769, 2003.
4. Yoshimatsu E, Takatsuka K, Iwabuchi S. Changes of portal hemodynamics and serum albumin levels in patients undergoing partial splenic embolization. Kanzo 48: 153-160, 2007 (Article in Japanese with an English abstract).
5. Picardi A, D'Avola D, Gentilucci UV, et al. Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes Metab Res Rev 22: 274-283, 2006.
6. Kuriyama S, Miwa Y, Fukushima H, et al. Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease. J Clin Biochem Nutr 40: 116-122, 2007.
7. Petrides AS, Riely CA, DeFronzo RA. Insulin resistance in non-cirrhotic idiopathic portal hypertension. Gastroenterology 100: 245-251, 1991.
8. Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31 Suppl 2: S262-S268, 2008.
9. Petrides AS, DeFronzo RA. Glucose and insulin metabolism in cirrhosis. J Hepatol 8: 107-114, 1989.
10. Romero-Gomez M. Hepatitis C and insulin resistance: steatosis, fibrosis and non-response. Rev Esp Enferm Dig 98: 605-615, 2006.
11. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126: 840-848, 2004.
12. Cao ZX, Chen XP, Wu ZD. Effects of splenectomy in patients with cirrhosis undergoing hepatic resection for hepatocellular carcinoma. World J Gastroenterol 9: 2460-2463, 2003.
13. Miyatake H, Kanto T, Inoue M, et al. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection. J Viral Hepat 14: 404-412, 2007.
14. Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 30: 398-408, 2004.